{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:35:27Z","timestamp":1786988127276,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ejphar.2013.08.019","type":"journal-article","created":{"date-parts":[[2013,9,4]],"date-time":"2013-09-04T20:45:34Z","timestamp":1378327534000},"page":"290-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Mineralocorticoid receptor antagonists attenuate pulmonary inflammation and bleomycin-evoked fibrosis in rodent models"],"prefix":"10.1016","volume":"718","author":[{"given":"Gissela B","family":"Lieber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiomara","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garfield G","family":"Mingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Caniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata A.","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanil","family":"Keshwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice D.","family":"Woodhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milenko","family":"Cicmil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily Y","family":"Moy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Crawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C","family":"Anthes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Klappenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Lu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbie L.","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2013.08.019_bib1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/eurheartj\/ehi023","article-title":"Spironolactone improves lung diffusion in chronic heart failure","volume":"26","author":"Agostoni","year":"2005","journal-title":"European Heart Journal"},{"key":"10.1016\/j.ejphar.2013.08.019_bib2","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1513\/pats.200807-069TH","article-title":"Future treatments for chronic obstructive pulmonary disease and its comorbidities","volume":"5","author":"Barnes","year":"2008","journal-title":"Proceedings of the American Thoracic Society"},{"key":"10.1016\/j.ejphar.2013.08.019_bib3","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1183\/09031936.00128008","article-title":"Systemic manifestations and comorbidities of COPD","volume":"33","author":"Barnes","year":"2009","journal-title":"European Respiratory Journal"},{"key":"10.1016\/j.ejphar.2013.08.019_bib4","first-page":"1342","article-title":"Rat and hamster species differences in susceptibility to elastase-induced pulmonary emphysema relate to differences in elastase inhibitory capacity","volume":"293","author":"Borzone","year":"2007","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.ejphar.2013.08.019_bib5","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1165\/rcmb.2007-0448OC","article-title":"Chronic LPS inhalation causes emphysema-like changes in mouse lung that are associated with apoptosis","volume":"39","author":"Brass","year":"2008","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.ejphar.2013.08.019_bib6","first-page":"893","article-title":"Mineralocorticoid excess, dietary sodium, and myocardial fibrosis","volume":"120","author":"Brilla","year":"1992","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"10.1016\/j.ejphar.2013.08.019_bib7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1042\/CS20120162","article-title":"Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions","volume":"123","author":"Burchill","year":"2012","journal-title":"Clinical Science"},{"key":"10.1016\/j.ejphar.2013.08.019_bib8","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1517\/14728222.11.10.1273","article-title":"Targeting systemic inflammation: novel therapies for the treatment of chronic obstructive pulmonary disease","volume":"11","author":"Cazzola","year":"2007","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"10.1016\/j.ejphar.2013.08.019_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejphar.2006.04.020","article-title":"Temporal profile of forced expiratory lung function in allergen-challenged Brown-Norway rats","volume":"540","author":"Celly","year":"2006","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.ejphar.2013.08.019_bib10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.pcad.2009.09.005","article-title":"The role of the renin-angiotensin-aldosterone system in renal artery stenosis, renovascular hypertension, and ischemic nephropathy: diagnostic implications","volume":"52","author":"Covic","year":"2009","journal-title":"Progress in Cardiovascular Diseases"},{"key":"10.1016\/j.ejphar.2013.08.019_bib11","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2144\/97224bm19","article-title":"Microassay for the assessment of low levels of hydroxyproline","volume":"22","author":"Creemers","year":"1997","journal-title":"Biotechniques"},{"key":"10.1016\/j.ejphar.2013.08.019_bib12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF00370222","article-title":"Regulation of Na+ channels in frog lung epithelium: a target tissue for aldosterone action","volume":"416","author":"Fischer","year":"1990","journal-title":"Pfl\u00fcgers Archiv: European Journal of Physiology"},{"key":"10.1016\/j.ejphar.2013.08.019_bib13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1161\/STROKEAHA.110.598441","article-title":"Myeloid-specific deletion of the mineralocorticoid receptor reduces infarct volume and alters inflammation during cerebral ischemia","volume":"42","author":"Frieler","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2013.08.019_bib14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MED.0b013e3283391989","article-title":"Aldosterone and inflammation","volume":"17","author":"Gilbert","year":"2010","journal-title":"Current Opinion in Endocrinology, Diabetes, and Obesity"},{"key":"10.1016\/j.ejphar.2013.08.019_bib15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1751-7176.2011.00449.x","article-title":"Renin-Angiotensin-aldosterone system in diabetes and hypertension","volume":"13","author":"Hsueh","year":"2011","journal-title":"Journal of Clinical Hypertension"},{"key":"10.1016\/j.ejphar.2013.08.019_bib16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2174\/1389557054553811","article-title":"Molecular mechanisms of mineralocorticoid receptor antagonism by eplerenone","volume":"5","author":"Hu","year":"2005","journal-title":"Mini Reviews in Medicinal Chemistry"},{"key":"10.1016\/j.ejphar.2013.08.019_bib17","first-page":"230","article-title":"Aldosterone regulation of basolateral potassium channels in alveolar epithelium","volume":"259","author":"Illek","year":"1990","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.ejphar.2013.08.019_bib18","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/archinte.163.10.1155","article-title":"Renin-angiotensin system and atherothrombotic disease: from genes to treatment","volume":"163","author":"Jacoby","year":"2003","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.ejphar.2013.08.019_bib19","first-page":"167","article-title":"The vogue in renal physiology: a review article","volume":"16","author":"Jones","year":"1970","journal-title":"Central African Journal of Medicine"},{"key":"10.1016\/j.ejphar.2013.08.019_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-4827(83)90282-3","article-title":"Inhibition of glucocorticosteroid action in cultured L-929 mouse fibroblasts by RU 486, a new anti-glucocorticosteroid of high affinity for the glucocorticosteroid receptor","volume":"147","author":"Jung-Testas","year":"1983","journal-title":"Experimental Cell Research,"},{"key":"10.1016\/j.ejphar.2013.08.019_bib21","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2174\/1566524013363401","article-title":"Molecular mechanisms of pulmonary fibrosis and current treatment","volume":"1","author":"Kuwano","year":"2001","journal-title":"Current Molecular Medicine"},{"key":"10.1016\/j.ejphar.2013.08.019_bib22","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1161\/01.CIR.0000039328.33137.6C","article-title":"Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone","volume":"106","author":"Lacolley","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2013.08.019_bib23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0300-483X(98)00025-0","article-title":"Induction of pulmonary fibrosis in organ-cultured rat lung by cadmium chloride and transforming growth factor-beta1","volume":"15","author":"Lin","year":"1998","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2013.08.019_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.abb.2008.09.019","article-title":"Losartan, an antagonist of AT1 receptor for angiotensin II, attenuates lipopolysaccharide-induced acute lung injury in rat","volume":"481","author":"Liu","year":"2009","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/j.ejphar.2013.08.019_bib25","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1001\/jama.2012.14785","article-title":"Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction","volume":"308","author":"Lund","year":"2012","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.ejphar.2013.08.019_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/CS20070123","article-title":"Aldosterone and end-organ damage","volume":"113","author":"Marney","year":"2007","journal-title":"Clinical Science"},{"key":"10.1016\/j.ejphar.2013.08.019_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1357-2725(96)00141-0","article-title":"The pathogenesis of pulmonary fibrosis: is there a fibrosis gene?","volume":"29","author":"Marshall","year":"1997","journal-title":"International Journal of Biochemistry & Cell Biology"},{"key":"10.1016\/j.ejphar.2013.08.019_bib28","first-page":"01381","article-title":"The past, present and future of renin-angiotensin aldosterone system inhibition","volume":"S0167-5273","author":"Mentz","year":"2012","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.ejphar.2013.08.019_bib29","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/thx.49.5.492","article-title":"Activity of the renin-angiotensin system in acute severe asthma and the effect of angiotensin II on lung function","volume":"49","author":"Millar","year":"1994","journal-title":"Thorax"},{"key":"10.1016\/j.ejphar.2013.08.019_bib30","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.biocel.2007.08.011","article-title":"The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?","volume":"40","author":"Moeller","year":"2008","journal-title":"International Journal of Biochemistry & Cell Biology"},{"key":"10.1016\/j.ejphar.2013.08.019_bib31","first-page":"752406","article-title":"The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies","author":"Montecucco","year":"2009","journal-title":"Mediators of Inflammation"},{"key":"10.1016\/j.ejphar.2013.08.019_bib32","first-page":"10","article-title":"Impact of statins and ACE inhibitors on mortality after COPD exacerbations","volume":"3","author":"Mortensen","year":"2009","journal-title":"Respiratory Research"},{"key":"10.1016\/j.ejphar.2013.08.019_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1164\/ajrccm.162.1.9907128","article-title":"Type 1 angiotensin II receptor antagonism reduces antigen-induced airway reactions","volume":"162","author":"Myou","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.ejphar.2013.08.019_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0083-6729(03)01002-1","article-title":"Aldosterone: its receptor, target genes, and actions","volume":"66","author":"Pearce","year":"2003","journal-title":"Vitamins and Hormones"},{"key":"10.1016\/j.ejphar.2013.08.019_bib35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/eurheartj\/16.suppl_N.107","article-title":"ACE inhibitor co-therapy in patients with heart failure: rationale for the Randomized Aldactone Evaluation Study (RALES)","volume":"16","author":"Pitt","year":"1995","journal-title":"European Heart Journal"},{"key":"10.1016\/j.ejphar.2013.08.019_bib36","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ejphar.2013.08.019_bib37","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ejphar.2013.08.019_bib38","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000015854.60710.10","article-title":"Mineralocorticoid receptor antagonism in experimental atherosclerosis","volume":"105","author":"Rajagopalan","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2013.08.019_bib39","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2217\/14622416.10.3.463","article-title":"Significance of genetic polymorphisms of the renin-angiotensin-aldosterone system in cardiovascular and renal disease","volume":"10","author":"Rudnicki","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ejphar.2013.08.019_bib40","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00408-011-9279-2","article-title":"Fibrotic response of tissue remodeling in COPD","volume":"189","author":"Salazar","year":"2011","journal-title":"Lung"},{"key":"10.1016\/j.ejphar.2013.08.019_bib41","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2337\/db08-0254","article-title":"(Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation","volume":"58","author":"Satofuka","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2013.08.019_bib42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0010-7824(83)80008-0","article-title":"Binding of the anti-progestin RU-486 to rat ovary steroid receptors","volume":"28","author":"Schreiber","year":"1983","journal-title":"Contraception"},{"key":"10.1016\/j.ejphar.2013.08.019_bib43","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s10495-006-0286-3","article-title":"Spironolactone induces apoptosis and inhibits NF-kappaB independent of the mineralocorticoid receptor","volume":"11","author":"S\u00f8nder","year":"2006","journal-title":"Apoptosis"},{"key":"10.1016\/j.ejphar.2013.08.019_bib44","doi-asserted-by":"crossref","first-page":"14942","DOI":"10.1073\/pnas.0903602106","article-title":"Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system","volume":"106","author":"Stegbauer","year":"2009","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.ejphar.2013.08.019_bib45","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/med.2610110604","article-title":"Mineralocorticoid receptor ligands: biochemical, pharmacological, and clinical aspects","volume":"11","author":"Sutanto","year":"1991","journal-title":"Medicinal Research Reviews"},{"key":"10.1016\/j.ejphar.2013.08.019_bib46","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1291\/hypres.27.781","article-title":"Pleiotropic actions of aldosterone and the effects of eplerenone, a selective mineralocorticoid receptor antagonist","volume":"27","author":"Takeda","year":"2004","journal-title":"Hypertension Research"},{"key":"10.1016\/j.ejphar.2013.08.019_bib47","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.cyto.2009.08.001","article-title":"Angiotensin II type-1 receptor antagonist attenuates LPS-induced acute lung injury","volume":"48","author":"Wang","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.ejphar.2013.08.019_bib48","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1097\/00029330-200811020-00018","article-title":"Effect of valsartan on the expression of angiotensin II receptors in the lung of chronic antigen exposure rats","volume":"121","author":"Wang","year":"2008","journal-title":"Chinese Medical Journal"},{"key":"10.1016\/j.ejphar.2013.08.019_bib49","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/BF01487550","article-title":"Renin-angiotensin-aldosterone system from the pathophysiological viewpoint","volume":"47","author":"Werning","year":"1969","journal-title":"Klinische Wochenschrift"},{"key":"10.1016\/j.ejphar.2013.08.019_bib50","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1152\/ajplung.90200.2008","article-title":"Animal models of chronic obstructive pulmonary disease","volume":"295","author":"Wright","year":"2008","journal-title":"American Journal of Physiology \u2013 Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.ejphar.2013.08.019_bib51","first-page":"300","article-title":"Spironolactone ameliorates rat pulmonary fibrosis induced by bleomycin A5","volume":"21","author":"Zhao","year":"1998","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"10.1016\/j.ejphar.2013.08.019_bib52","first-page":"750","article-title":"An experimental study on airway inflammation and remodeling in a rat model of chronic bronchitis and emphysema","volume":"26","author":"Zhong","year":"2003","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913006092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913006092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T05:44:24Z","timestamp":1563860664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299913006092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":52,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0014299913006092"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.08.019","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mineralocorticoid receptor antagonists attenuate pulmonary inflammation and bleomycin-evoked fibrosis in rodent models","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}